創建日期 | 上市日期 | 董事長 | 總經理 |
---|---|---|---|
41/03/12 | 51/02/09 | 王謝怡貞 | 吳志庸 |
EPS | 本益比 | 股價淨值比 | 現金殖利率 |
0.18(Q2) | 17.92 | 0.94 | 3.43% |
實收資本額 | 已發行普通股 | ||
2,980,810,800 | 298,081,080 | ||
主要經營業務 | |||
醫藥品、農畜藥品、個人衛生保健用品、醫療儀器之進口、買賣 | |||
公司網址 | |||
ccpc.com.tw |
中化(1701) 月營收報表
年度/月份 | 營業收入(單位:千元) | 累計營業收入(單位:千元) | |||||
---|---|---|---|---|---|---|---|
單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
2023/08 | 711,815 | 678,623 | 2.9% | 4.9% | 5,634,453 | 5,374,000 | 4.8% |
2023/07 | 691,536 | 659,390 | -5.2% | 4.9% | 4,922,638 | 4,695,377 | 4.8% |
2023/06 | 729,551 | 711,385 | 4.4% | 2.5% | 4,231,102 | 4,035,987 | 4.8% |
2023/05 | 698,521 | 694,902 | 0.7% | 0.5% | 3,501,551 | 3,324,602 | 5.3% |
2023/04 | 693,843 | 678,926 | -2.4% | 2.2% | 2,803,030 | 2,629,700 | 6.6% |
2023/03 | 710,635 | 679,100 | 10.1% | 4.6% | 2,109,187 | 1,950,774 | 8.1% |
2023/02 | 645,122 | 530,948 | -14.4% | 21.5% | 1,398,552 | 1,271,674 | 10% |
2023/01 | 753,430 | 740,726 | -19.3% | 1.7% | 753,430 | 740,726 | 1.7% |
2022/12 | 736,352 | 713,668 | 1.6% | 3.2% | 8,258,990 | 7,979,639 | 3.5% |
2022/11 | 724,997 | 679,023 | 4.3% | 6.8% | 7,522,638 | 7,265,971 | 3.5% |
2022/10 | 694,895 | 633,230 | -4.6% | 9.7% | 6,797,641 | 6,586,948 | 3.2% |
2022/09 | 728,746 | 654,963 | 7.4% | 11.3% | 6,102,746 | 5,953,718 | 2.5% |
2022/08 | 678,623 | 614,507 | 2.9% | 10.4% | 5,374,000 | 5,298,755 | 1.4% |
2022/07 | 659,390 | 632,685 | -7.3% | 4.2% | 4,695,377 | 4,684,248 | 0.2% |
2022/06 | 711,385 | 677,409 | 2.4% | 5% | 4,035,987 | 4,051,563 | -0.4% |
2022/05 | 694,902 | 717,855 | 2.3% | -3.2% | 3,324,602 | 3,374,154 | -1.5% |
2022/04 | 678,926 | 647,486 | 0% | 4.8% | 2,629,700 | 2,656,299 | -1% |
2022/03 | 679,100 | 622,390 | 27.9% | 9.1% | 1,950,774 | 2,008,813 | -2.9% |
2022/02 | 530,948 | 522,933 | -28.3% | 1.5% | 1,271,674 | 1,386,423 | -8.3% |
2022/01 | 740,726 | 863,490 | 3.8% | -14.2% | 740,726 | 863,490 | -14.2% |
2021/12 | 713,668 | 736,343 | 5.1% | -3.1% | 7,979,639 | 8,146,491 | -2% |
2021/11 | 679,023 | 731,270 | 7.2% | -7.1% | 7,265,971 | 7,410,148 | -1.9% |
2021/10 | 633,230 | 613,931 | -3.3% | 3.1% | 6,586,948 | 6,678,878 | -1.4% |
2021/09 | 654,963 | 753,371 | 6.6% | -13.1% | 5,953,718 | 6,064,947 | -1.8% |
2021/08 | 614,507 | 626,738 | -2.9% | -2% | 5,298,755 | 5,311,576 | -0.2% |
2021/07 | 632,685 | 634,856 | -6.6% | -0.3% | 4,684,248 | 4,684,838 | 0% |
2021/06 | 677,409 | 617,720 | -5.6% | 9.7% | 4,051,563 | 4,049,982 | 0% |
2021/05 | 717,855 | 625,512 | 10.9% | 14.8% | 3,374,154 | 3,432,262 | -1.7% |
2021/04 | 647,486 | 701,073 | 4% | -7.6% | 2,656,299 | 2,806,750 | -5.4% |
2021/03 | 622,390 | 728,371 | 19% | -14.6% | 2,008,813 | 2,105,677 | -4.6% |
2021/02 | 522,933 | 640,025 | -39.4% | -18.3% | 1,386,423 | 1,377,306 | 0.7% |
2021/01 | 863,490 | 737,281 | 17.3% | 17.1% | 863,490 | 737,281 | 17.1% |
2020/12 | 736,343 | 672,901 | 0.7% | 9.4% | 8,146,491 | 7,957,816 | 2.4% |
2020/11 | 731,270 | 684,393 | 19.1% | 6.8% | 7,410,148 | 7,284,915 | 1.7% |
2020/10 | 613,931 | 671,164 | -18.5% | -8.5% | 6,678,878 | 6,600,522 | 1.2% |
2020/09 | 753,371 | 667,515 | 20.2% | 12.9% | 6,064,947 | 5,929,358 | 2.3% |
恆大(1325) 歷年營收季增率
年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
---|---|---|---|---|---|
2023Q2 | -5.91% | -9.22% | 2020Q3 | 6.78% | 56.74% |
2023Q1 | -5.82% | -7.28% | 2020Q2 | 189.74% | 101.09% |
2022Q4 | -15.02% | -5.58% | 2020Q1 | 144.11% | 30.08% |
2022Q3 | -8.97% | -5.19% | 2019Q4 | -1.24% | -8.93% |
2022Q2 | 0.36% | -28.91% | 2019Q3 | -20.79% | -4.35% |
2022Q1 | 0.55% | -26.92% | 2019Q2 | 14.58% | 0.70% |
2021Q4 | -11.81% | -43.44% | 2019Q1 | -22.08% | -3.66% |
2021Q3 | -57.94% | -35.43% | 2018Q4 | 16.15% | 3.89% |
2021Q2 | -14.57% | -20.45% | 2018Q3 | -0.83% | 0.82% |
2021Q1 | -55.76% | 1.05% | 2018Q2 | -4.85% | 0.75% |
2020Q4 | -19.67% | 28.05% | 2018Q1 | 5.66% | 0.16% |
評論0